Display Settings:

Format

Send to:

Choose Destination
    Genome Res. 2007 Aug;17(8):1195-201. Epub 2007 Jun 28.

    Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance.

    Source

    Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, CA 94305, USA.

    Abstract

    The detection of mutant spectra within a population of microorganisms is critical for the management of drug-resistant infections. We performed ultra-deep pyrosequencing to detect minor sequence variants in HIV-1 protease and reverse transcriptase (RT) genes from clinical plasma samples. We estimated empirical error rates from four HIV-1 plasmid clones and used them to develop a statistical approach to distinguish authentic minor variants from sequencing errors in eight clinical samples. Ultra-deep pyrosequencing detected an average of 58 variants per sample compared with an average of eight variants per sample detected by conventional direct-PCR dideoxynucleotide sequencing. In the clinical sample with the largest number of minor sequence variants, all 60 variants present in > or =3% of genomes and 20 of 35 variants present in <3% of genomes were confirmed by limiting dilution sequencing. With appropriate analysis, ultra-deep pyrosequencing is a promising method for characterizing genetic diversity and detecting minor yet clinically relevant variants in biological samples with complex genetic populations.

    PMID:
    17600086
    [PubMed - indexed for MEDLINE]
    PMCID: PMC1933516
    Free PMC Article

    Images from this publication.See all images (2) Free text

    Figure 1.
    Figure 2.

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk